Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to 24.29%.

  • Cryo Cell International's EBIT Margin rose 70600.0% to 24.29% in Q3 2025 from the same period last year, while for Aug 2025 it was 13.63%, marking a year-over-year increase of 531200.0%. This contributed to the annual value of 10.88% for FY2024, which is 501400.0% up from last year.
  • Per Cryo Cell International's latest filing, its EBIT Margin stood at 24.29% for Q3 2025, which was up 70600.0% from 18.83% recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's EBIT Margin ranged from a high of 27.69% in Q2 2021 and a low of 205.37% during Q4 2023
  • Moreover, its 5-year median value for EBIT Margin was 15.65% (2022), whereas its average is 2.81%.
  • Per our database at Business Quant, Cryo Cell International's EBIT Margin plummeted by -2105900bps in 2023 and then surged by 2038400bps in 2024.
  • Cryo Cell International's EBIT Margin (Quarter) stood at 11.05% in 2021, then surged by 147bps to 5.22% in 2022, then plummeted by -4033bps to 205.37% in 2023, then skyrocketed by 99bps to 1.52% in 2024, then soared by 1693bps to 24.29% in 2025.
  • Its last three reported values are 24.29% in Q3 2025, 18.83% for Q2 2025, and 13.25% during Q1 2025.